Cargando…

Correction: Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease

Detalles Bibliográficos
Autores principales:	Nunes, Marielza Andrade, Schöwe, Natalia Mendes, Monteiro-Silva, Karla Cristina, Baraldi-Tornisielo, Ticiana, Souza, Suzzanna Ingryd Gonçalves, Balthazar, Janaina, Albuquerque, Marilia Silva, Caetano, Ariadiny Lima, Viel, Tania Araujo, Buck, Hudson Sousa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682978/ https://www.ncbi.nlm.nih.gov/pubmed/26678744 http://dx.doi.org/10.1371/journal.pone.0145695

Ejemplares similares

Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease
por: Nunes, Marielza Andrade, et al.
Publicado: (2015)

Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?
por: Viel, Tania, et al.
Publicado: (2020)

Enriched Environment Significantly Reduced Senile Plaques in a Transgenic Mice Model of Alzheimer’s Disease, Improving Memory
por: Balthazar, Janaina, et al.
Publicado: (2018)

Hypervascular Lesion in a Cirrhotic Liver: A Case Report
por: Santos, Lucas Carvalho, et al.
Publicado: (2014)

Dataset for the role of sustained attention in memory formation of transgenic mice for Alzheimer׳s disease
por: Schöwe, Natalia Mendes, et al.
Publicado: (2016)

Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model
por: Nunes, Marielza Andrade, et al.
Publicado: (2020)

Microdose Lithium Protects against Pancreatic Islet Destruction and Renal Impairment in Streptozotocin-Elicited Diabetes
por: Zhang, Jiahui, et al.
Publicado: (2021)

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2019)

Microdosing: Concept, Application and Relevance
por: Tewari, Tushar, et al.
Publicado: (2010)

Asking questions of psychedelic microdosing
por: Cameron, Lindsay P
Publicado: (2021)

A systematic study of microdosing psychedelics
por: Polito, Vince, et al.
Publicado: (2019)

The therapeutic potential of microdosing psychedelics in depression
por: Kuypers, Kim P.C.
Publicado: (2020)

BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology
por: Wilson, E N, et al.
Publicado: (2017)

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers
por: Rootman, Joseph M., et al.
Publicado: (2021)

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022)

Phase 0 - Microdosing strategy in clinical trials
por: Rani, P. Usha, et al.
Publicado: (2008)

Psychedelic microdosing benefits and challenges: an empirical codebook
por: Anderson, Thomas, et al.
Publicado: (2019)

Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022)

Motives and Side-Effects of Microdosing With Psychedelics Among Users
por: Hutten, Nadia R P W, et al.
Publicado: (2019)

Self-blinding citizen science to explore psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2021)

Buprenorphine Microdosing Cross Tapers: A Time for Change
por: Raheemullah, Amer, et al.
Publicado: (2022)

Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
por: Pasquale, Louis R, et al.
Publicado: (2018)

Disease Detection by Ultrasensitive Quantification of Microdosed Synthetic Urinary Biomarkers
por: Warren, Andrew D., et al.
Publicado: (2014)

A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012)

Microbial population dynamics under microdoses of the essential oil arborvitae
por: McGregor, Rhegan C., et al.
Publicado: (2019)

Powerful substances in tiny amounts: An interview study of psychedelic microdosing
por: Johnstad, Petter Grahl
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series
por: Menard, Shannon, et al.
Publicado: (2022)

Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health
por: Ryan, Rebecca S., et al.
Publicado: (2023)

Subjective and Objective Measurements of the Facial Effects of Microdoses of Botulinum Toxin
por: Hexsel, Doris, et al.
Publicado: (2023)

Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report
por: Ruver-Martins, Ana Carolina, et al.
Publicado: (2022)

Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting
por: Prochazkova, Luisa, et al.
Publicado: (2018)

Dose‐linearity of the pharmacokinetics of an intravenous [(14)C]midazolam microdose in children
por: van Groen, Bianca D., et al.
Publicado: (2019)

Intratarget Microdosing for Deep Phenotyping of Multiple Drug Effects in the Live Brain
por: Kim, Jennifer, et al.
Publicado: (2022)

Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
por: Cavanna, Federico, et al.
Publicado: (2022)

Ibogaine microdosing in a patient with bipolar depression: a case report
por: Fernandes-Nascimento, Maria Helha, et al.
Publicado: (2022)

Automated Microdosing System for Integration With a Miniaturized High-pressure Reactor System
por: Stoll, Norbert, et al.
Publicado: (2005)

Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development
por: Burt, T, et al.
Publicado: (2016)

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
por: Kuypers, Kim PC, et al.
Publicado: (2019)

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
por: Kaertner, L. S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_abta3vsbdlkobiupop6r7j6a7p